Watch for Autoimmune-Like Effects From Cancer Immunotherapy

October 2018

More patients using cancer immunotherapy will lead to questions about adverse effects with "immune checkpoint inhibitors."

Cancer immunotherapy works by teaching the patient's immune system to find and kill cancer cells. It's different from chemotherapy, which directly targets dividing cells...malignant or healthy.

Common immunotherapies include immune checkpoint inhibitors, such as pembrolizumab (Keytruda) or durvalumab (Imfinzi). They block signals that cancer cells use to disguise themselves from the immune system.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote